Log in to search using one of your social media accounts:

 

Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Calais, J., Fendler, W. P., Herrmann, K., Eiber, M., Ceci, F. Tags: Letters Source Type: research

Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Denes, B., Gardiner, P. Tags: Letters Source Type: research

Molecular Imaging: An Introduction
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Kim, E. E. Tags: Book Reviews Source Type: research

Erratum
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Tags: Erratum Source Type: research

Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
Conclusion: ZeDD CT produces natural-looking and quantitatively accurate pseudo-CT images and reduces error in pelvic PET/MRI attenuation correction compared with standard methods. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Leynes, A. P., Yang, J., Wiesinger, F., Kaushik, S. S., Shanbhag, D. D., Seo, Y., Hope, T. A., Larson, P. E. Z. Tags: Clinical Source Type: research

Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
Conclusion: Our preliminary data indicate that running an fxPET scanner near an existing MRI system provides visually and quantitatively acceptable fused PET/MR images for diagnosis of malignant lesions. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Nakamoto, R., Nakamoto, Y., Ishimori, T., Fushimi, Y., Kido, A., Togashi, K. Tags: Clinical Source Type: research

18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
Activated macrophages have been known to play pivotal roles in the pathogenesis of rheumatoid arthritis (RA). 18F-FEDAC (N-benzyl-N-methyl-2-[7,8-dihydro-7-(2-18F-fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide) is a radiolabeled ligand for the 18-kDa translocator protein (TSPO), which is abundant in activated macrophages. We evaluated the feasibility of using 18F-FEDAC in a murine RA model. Methods: RAW 264.7 mouse macrophages were activated by lipopolysaccharide. TSPO expression levels in activated and inactivated macrophages were measured by quantitative polymerase chain reaction and Western blotting. The cellular u...
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Chung, S.-J., Yoon, H.-J., Youn, H., Kim, M. J., Lee, Y.-S., Jeong, J. M., Chung, J.-K., Kang, K. W., Xie, L., Zhang, M.-R., Cheon, G. J. Tags: Basic Source Type: research

Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
Conclusion: Depending on whether female or male mice are used, differences in biodistribution and nonspecific tissue uptake can adversely affect quantitative measures of 18F-FLT uptake. Thus, sex is a potential variable to consider in defining quantitative imaging metrics using 18F-FLT to assess tumor proliferation. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Chan, S. R., Salem, K., Jeffery, J., Powers, G. L., Yan, Y., Shoghi, K. I., Mahajan, A. M., Fowler, A. M. Tags: Basic Source Type: research

Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
Precise regional quantitative assessment of renal function is limited with conventional 99mTc-labeled renal radiotracers. A recent study reported that the PET radiotracer 2-deoxy-2-18F-fluorosorbitol (18F-FDS) has ideal pharmacokinetics for functional renal imaging. Furthermore, 18F-FDS is available via simple reduction from routinely used 18F-FDG. We aimed to further investigate the potential of 18F-FDS PET as a functional renal imaging agent using rat models of kidney disease. Methods: Two different rat models of renal impairment were investigated: induction of acute renal failure by intramuscular administration of glyce...
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Werner, R. A., Wakabayashi, H., Chen, X., Hirano, M., Shinaji, T., Lapa, C., Rowe, S. P., Javadi, M. S., Higuchi, T. Tags: Basic Source Type: research

Spatiotemporal Distribution of {beta}-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
Conclusion: The in vivo spatiotemporal distribution of Aβ in AD can be mathematically modeled using a logistic growth model in which the Aβ carrying capacity is heterogeneous across the brain but the exponential growth rate and time of half maximal Aβ concentration are constant. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Whittington, A., Sharp, D. J., Gunn, R. N., for the Alzheimers Disease Neuroimaging Initiative Tags: Clinical Source Type: research

Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors
Conclusion: These results suggest the potential usefulness of FIBG as a diagnostic and therapeutic agent for the management of norepinephrine transporter (NET)–expressing tumors. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Yamaguchi, A., Hanaoka, H., Higuchi, T., Tsushima, Y. Tags: Clinical Source Type: research

177Lu-3BP-227 for Neurotensin Receptor 1-Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
Conclusion: This initial report provides clinical evidence of the feasibility of treatment of ductal pancreatic adenocarcinoma using 177Lu-3BP-227. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Baum, R. P., Singh, A., Schuchardt, C., Kulkarni, H. R., Klette, I., Wiessalla, S., Osterkamp, F., Reineke, U., Smerling, C. Tags: Clinical Source Type: research

Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
Conclusion: 68Ga-RM2 PET can be used for assessment of GRPr expression in patients with BCR of PCa. High uptake in multiple areas compatible with cancer lesions suggests that 68Ga-RM2 is a promising PET radiopharmaceutical for localization of disease in patients with BCR of PCa and negative findings on conventional imaging. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Minamimoto, R., Sonni, I., Hancock, S., Vasanawala, S., Loening, A., Gambhir, S. S., Iagaru, A. Tags: Clinical Source Type: research

Targeted {alpha}-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
Conclusion: A positive response for surrogate parameters demonstrates remarkable antitumor activity for 225Ac-PSMA-617. Swimmer-plot analysis indicates a promising duration of tumor control, especially considering the unfavorable prognostic profile of the selected advanced-stage patients. Xerostomia was the main reason patients discontinued therapy or refused additional administrations and was in the same dimension as nonresponse; this finding indicates that further modifications of the treatment regimen with regard to side effects might be necessary to further enhance the therapeutic range. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Kratochwil, C., Bruchertseifer, F., Rathke, H., Hohenfellner, M., Giesel, F. L., Haberkorn, U., Morgenstern, A. Tags: Clinical Source Type: research

Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
Conclusion: This case series suggests improved detection rates for 68Ga-PSMA-11 PET/CT when compared with 18F-fluciclovine PET/CT in patients with recurrent PCa. Prospective trials designed to directly compare the two should be initiated. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Calais, J., Fendler, W. P., Herrmann, K., Eiber, M., Ceci, F. Tags: Clinical Source Type: research

Molecular Imaging of Prostate Cancer: Choosing the Right Agent
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Rowe, S. P., Pomper, M. G., Gorin, M. A. Tags: Clinical Source Type: research

Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
Conclusion: DLCs could represent a promising adjunctive therapy for restoring iodide avidity within the full spectrum from RAI-refractory dedifferentiated to ATC. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Tesselaar, M. H., Crezee, T., Schuurmans, I., Gerrits, D., Nagarajah, J., Boerman, O. C., van Engen-van Grunsven, I., Smit, J. W. A., Netea-Maier, R. T., Plantinga, T. S. Tags: Translational Source Type: research

18F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
Conclusion: 18F-FDG PET/CT results may act as a biomarker for the presence of a BRAF mutation, aid in establishing a diagnosis, guide biopsies, and gauge the treatment response in ECD patients. Axial and pelvic skeletal involvement is greater than previously reported. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Young, J. R., Johnson, G. B., Murphy, R. C., Go, R. S., Broski, S. M. Tags: Clinical Source Type: research

Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
Conclusion: Random survival forests are a simple and straightforward machine-learning approach for prediction of overall survival. The predictive performance of the trained model was similar to a previously published Cox regression model. The model has revealed a strong predictive value for baseline cholinesterase and bilirubin levels with a highly nonlinear influence for each parameter. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Ingrisch, M., Schoppe, F., Paprottka, K., Fabritius, M., Strobl, F. F., De Toni, E. N., Ilhan, H., Todica, A., Michl, M., Paprottka, P. M. Tags: Clinical Source Type: research

Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
Conclusion: Combined 18F-fluciclovine PET/multiparametric MRI shows potential for improving detection and characterization of high-risk prostate cancer, in comparison to MRI and PET alone. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Elschot, M., Selnaes, K. M., Sandsmark, E., Kruger-Stokke, B., Storkersen, O., Giskeodegard, G. F., Tessem, M.-B., Moestue, S. A., Bertilsson, H., Bathen, T. F. Tags: Clinical Source Type: research

Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Therapeutic options in advanced medullary thyroid carcinoma (MTC) have markedly improved since the introduction of tyrosine kinase inhibitors (TKIs). We aimed to assess the role of metabolic imaging using 18F-FDG PET/CT shortly before and 3 mo after initiation of TKI treatment. Methods: Eighteen patients with advanced and progressive MTC scheduled for vandetanib treatment underwent baseline 18F-FDG PET/CT before and 3 mo after TKI treatment initiation. During follow-up, CT scans were obtained every 3 mo and analyzed according to RECIST. The predictive value for estimating progression-free survival (PFS) and overall surviva...
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Werner, R. A., Schmid, J.-S., Higuchi, T., Javadi, M. S., Rowe, S. P., Markl, B., Aulmann, C., Fassnacht, M., Kroiss, M., Reiners, C., Buck, A. K., Kreissl, M. C., Lapa, C. Tags: Clinical Source Type: research

18F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation
This study aimed to assess the overall and thyroid cancer–specific survival in a large cohort of patients with 18F-FDG–avid TI with long-term follow-up to assess the validity of this approach. Methods: Retrospective review of 45,680 PET/CT scans performed at a comprehensive cancer center from January 2007 to January 2015 identified 2,588 18F-FDG PET/CT reports referring to the thyroid. After exclusion of nonavid thyroid nodules, diffuse 18F-FDG uptake, known thyroid cancer, abnormalities adjacent to the thyroid, and repeat studies, 500 patients (1.1%) with TI were identified, of whom 362 had confirmed death or ...
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Pattison, D. A., Bozin, M., Gorelik, A., Hofman, M. S., Hicks, R. J., Skandarajah, A. Tags: Clinical Source Type: research

PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Taieb, D., Foletti, J.-M., Bardies, M., Rocchi, P., Hicks, R. J., Haberkorn, U. Tags: Editorials Source Type: research

Advanced Ultrasound Technologies for Diagnosis and Therapy
This article provides an overview of recent developments in diagnostic and therapeutic ultrasound, highlighting multiple innovation tracks and their translational potential. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Rix, A., Lederle, W., Theek, B., Lammers, T., Moonen, C., Schmitz, G., Kiessling, F. Tags: Focus on Molecular Imaging Source Type: research

Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
PET is a functional imaging method that can exploit various aspects of tumor biology to enable greater detection of prostate cancer than can be provided by morphologic imaging alone. Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic acid (18F-fluciclovine) is a nonnaturally occurring amino acid PET radiotracer that was recently approved by the U.S. Food and Drug Administration for detection of suspected recurrent prostate cancer. The tumor-imaging features of this radiotracer mirror the upregulation of transmembrane amino acid transport that occurs in prostate cancer because of increased amino acid metabolism for energy and...
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Parent, E. E., Schuster, D. M. Tags: Continuing Education Source Type: research

Molecular Imaging in Cancer Drug Development
Development of new oncology drugs has increased since the improved understanding of cancer’s complex biology. The oncology field has become the top therapeutic research area for new drugs. However, only a limited number of drugs entering clinical trials will be approved for use as the standard of care for cancer patients. Molecular imaging is increasingly perceived as a tool to support go/no-go decisions early during drug development. It encompasses a wide range of techniques that include radiolabeling a compound of interest followed by visualization with SPECT or PET. Radiolabeling can be performed using a variety o...
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Waaijer, S. J. H., Kok, I. C., Eisses, B., Schroder, C. P., Jalving, M., Brouwers, A. H., Lub-de Hooge, M. N., de Vries, E. G. E. Tags: The State of the Art Source Type: research

Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Tulchinsky, M., Binse, I., Campenni, A., Dizdarevic, S., Giovanella, L., Jong, I., Kairemo, K., Kim, C. K. Tags: Hot Topics Source Type: research

Aetna and 68Ga-DOTATATE: A Sequel to "The Injustice of Being Judged by the Errors of Others" (1)
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Czernin, J., Ceci, F. Tags: Editor ' s Page Source Type: research

From the Literature
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Tags: SNMMI Newsline Source Type: research

Newsbriefs
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Tags: SNMMI Newsline Source Type: research

SNMMI Leadership Update: A Strong SNMMI
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Pappas, V. Tags: SNMMI Newsline Source Type: research

RADAR Develops New Generation of Dosimetry Phantoms
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Stabin, M. G., Siegel, J. A., Xu, X. G., for the RAdiation Dose Assessment Resource Committee of the SNMMI Tags: SNMMI Newsline Source Type: research

Fifty Years Ago in JNM
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Tags: SNMMI Newsline Source Type: research

Wessels to Be Recognized with Loevinger-Berman Award
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Howell, R. W., Sgouros, G., on behalf of the SNMMI Medical Internal Radiation Dose Committee Tags: SNMMI Newsline Source Type: research

Reclassifying Diagnostic Radiopharmaceuticals
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Tags: SNMMI Newsline Source Type: research

NRC Advisory Committee on Medical Uses of Isotopes Spring Meeting
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Authors: Kubler, C. B. Tags: SNMMI Newsline Source Type: research

This Month in JNM
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - May 1, 2018 Category: Nuclear Medicine Tags: This Month in JNM Source Type: research

Research, Research, Otherwise We Are lost!
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Ekmekcioglu, O. Tags: Letters Source Type: research

Reply: Cerebrospinal Fluid, Hyposmia, and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: de Leon, M. J., Li, Y., Rusinek, H. Tags: Letters Source Type: research

Cerebrospinal Fluid, Hyposmia, and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Kumaria, A. Tags: Letters Source Type: research

Reply: Molecular Imaging of Bacteria in Patients Is an Attractive Fata Morgana, Not a Realistic Option
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Lawal, I., Ankrah, A., Sathekge, M. Tags: Letters Source Type: research

Molecular Imaging of Bacteria in Patients Is an Attractive Fata Morgana, Not a Realistic Option
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Hess, S., Alavi, A., Werner, T., Hoilund-Carlsen, P. F. Tags: Letters Source Type: research

Reply: Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Delgado-Bolton, R., Esposito, G., Colletti, P. M., Jadvar, H. Tags: Letters Source Type: research

Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Kanoun, S., Cottereau, A.-S., Berriolo-Riedinger, A., Meignan, M., Casasnovas, O., Courbon, F., Kraeber-Bodere, F. Tags: Letters Source Type: research

Reply: Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders?
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Sambuceti, G., Morbelli, S., Cossu, V., Marini, C., Bauckneht, M. Tags: Letters Source Type: research

Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders?
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Finessi, M., Nicolotti, D. G., Bisi, G., Deandreis, D. Tags: Letters Source Type: research

Reply: Optimizing Strategies for Immune Checkpoint Imaging with Immuno-PET in Preclinical Study
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Mayer, A. T., Gambhir, S. S. Tags: Letters Source Type: research

Optimizing Strategies for Immune Checkpoint Imaging with Immuno-PET in Preclinical Study
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Chen, J., Wang, N., Yang, X., Li, Y. Tags: Letters Source Type: research

Erratum
(Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Tags: Errata Source Type: research